|
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
Recent news on
Nalbuphine
Penwest Reports First Quarter 2007 Financial Results - Apr 26, 2007 PR Newswire (press release),The increase in R&D expense reflects increased spending on the development of nalbuphine ER, which was largely offset by decreased expense recorded for
Penwest Reports First Quarter 2007 Financial Results - 26 Apr 2007 PR Newswire (press release),The increase in R&D expense reflects increased spending on the development of nalbuphine ER, which was largely offset by decreased expense recorded for
Penwest Reports Fourth Quarter and Year End 2006 Financial Results - Mar 12, 2007 Drug Newswire (press release),We plan to advance both nalbuphine ER, our compound under development for moderate, chronic pain, and torsemide ER into Phase II studies this year,
City cops nab shabu pusher at checkpoint - Mar 5, 2007 Bohol Chronicle,...commonly known as 'shabu', one ampule of nalbuphine hydrochloride (nubain), 1 syringe and more than P3,000 cash in different denominations.
FTC Challenges Hospira/Mayne Pharma Deal - 18 Jan 2007 PharmaLive.com (press release),Nalbuphine Hydrochloride. Nalbuphine is an injectable opioid analgesic also used to relieve moderate-to-severe pain. Hospira currently is the only supplier
Penwest to Participate In Upcoming Conferences - Nov 28, 2006 Drug Newswire (press release),...regulatory risks relating to drugs in development such as, torsemide ER and nalbuphine ER, including the timing and outcome of regulatory action;
This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional
|